1. Home
  2. NTHI vs CURV Comparison

NTHI vs CURV Comparison

Compare NTHI & CURV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTHI
  • CURV
  • Stock Information
  • Founded
  • NTHI 2008
  • CURV 2001
  • Country
  • NTHI United States
  • CURV United States
  • Employees
  • NTHI N/A
  • CURV N/A
  • Industry
  • NTHI Biotechnology: Pharmaceutical Preparations
  • CURV Clothing/Shoe/Accessory Stores
  • Sector
  • NTHI Health Care
  • CURV Consumer Discretionary
  • Exchange
  • NTHI Nasdaq
  • CURV Nasdaq
  • Market Cap
  • NTHI 211.9M
  • CURV 185.4M
  • IPO Year
  • NTHI N/A
  • CURV 2021
  • Fundamental
  • Price
  • NTHI $9.80
  • CURV $1.25
  • Analyst Decision
  • NTHI
  • CURV Hold
  • Analyst Count
  • NTHI 0
  • CURV 6
  • Target Price
  • NTHI N/A
  • CURV $3.03
  • AVG Volume (30 Days)
  • NTHI 42.0K
  • CURV 510.7K
  • Earning Date
  • NTHI 11-19-2025
  • CURV 12-02-2025
  • Dividend Yield
  • NTHI N/A
  • CURV N/A
  • EPS Growth
  • NTHI N/A
  • CURV N/A
  • EPS
  • NTHI N/A
  • CURV 0.03
  • Revenue
  • NTHI $59,990.00
  • CURV $1,068,099,000.00
  • Revenue This Year
  • NTHI N/A
  • CURV N/A
  • Revenue Next Year
  • NTHI N/A
  • CURV N/A
  • P/E Ratio
  • NTHI N/A
  • CURV $42.73
  • Revenue Growth
  • NTHI N/A
  • CURV N/A
  • 52 Week Low
  • NTHI $3.20
  • CURV $1.22
  • 52 Week High
  • NTHI $25.00
  • CURV $7.19
  • Technical
  • Relative Strength Index (RSI)
  • NTHI N/A
  • CURV 25.45
  • Support Level
  • NTHI N/A
  • CURV $1.34
  • Resistance Level
  • NTHI N/A
  • CURV $1.48
  • Average True Range (ATR)
  • NTHI 0.00
  • CURV 0.09
  • MACD
  • NTHI 0.00
  • CURV -0.00
  • Stochastic Oscillator
  • NTHI 0.00
  • CURV 7.57

About NTHI NeOnc Technologies Holdings Inc. Common Stock

NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).

About CURV Torrid Holdings Inc.

Torrid Holdings Inc is a direct-to-consumer brand of apparel, intimates, and accessories in North America. The company is focused on fit and offers high-quality products across a broad assortment that includes tops, bottoms, denim, dresses, intimates, activewear, footwear, and accessories. The company has one reportable segment, which includes the operation of the e-commerce platform and stores. The company generates revenue from the sale of apparel, intimates, and accessories through its e-commerce platform and its store locations.

Share on Social Networks: